Bremelanotide PT-141

• Post Date:

  Jul 02,2013

• Expiry Date:

  Dec 29,2013

• Detailed Description:

  Cas No. :189691-06-3 Bremelanotide PT-141
  
  Systematic (IUPAC) name
  (3S,6S,9R,12S,15S,23S)-15-[(N-acetyl-L-norleucyl)amino]-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaa zacyclotricosane-23-carboxylic acid
  Clinical data
  Legal status Unscheduled (US)
  Pharmacokinetic data
  Half-life 120 minutes[1]
  Identifiers
  CAS number 189691-06-3
  Chemical data
  Formula C50H68N14O10 
  Mol. mass 1025.2 g/mol
  PT-141 Side Effects
  
  Despite promising results and excellent safety profile, the PT-141 Nasal Spray formulation was denied regulatory approval by the FDA due to concerns about rises in blood pressure. However, since these concerns aren't apparent with the injectable PT-141, as the product takes longer to reach peak levels in the body, this may be available on the market as a prescription drug in the coming years.
  
  Package
  10vials/pack; 12vials/pack; 5vials/pack
  10mg/vial; 5mg/vial
  We can pack according to your requests
  
  

• CAS Registry Number:

  189691-06-3

• Synonyms:

  BREMELANOTIDE;Brmelanotice;Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys)-OH;(3S,6S,9R,12S,23S)-15-[(N-acetyl-L-norleucyl)amino]-9-benzyl-6-{3-[(diaminomethylidene)amino]propyl}-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxylic acid;Brmelanotide;PT141;Bromelanotide;Bremelanotide (PT-141);

• Molecular Formula:

  C₅₀H₆₈N₁₄O₁₀

• Molecular Weight:

  1025.1627

• Molecular Structure:

  

• Company:

  Hubei Maxsource Chem Co., Ltd....     [ China ]        

• Contact:

  Jake Young

• Tel:

  +86-027-83555670

• Fax:

  +86-027-83555670

• Email:

  maxsource11@yahoo.com